Literature DB >> 3298078

An immunohistological study of cells infiltrating progressive and regressive tumors induced by two variant subpopulations of a rat colon cancer cell line.

M S Martin, A Caignard, A Hammann, H Pelletier, F Martin.   

Abstract

In order to understand the mechanisms leading up to progression or regression, tumors resulting from the s.c. inoculation of progressive or regressive variants of a cell culture established from a chemically-induced rat colonic carcinoma were subjected to sequential histological study. As immunological factors have been previously described in this system of progressive or regressive tumors, special interest was given to inflammatory cells, T and B lymphocytes and macrophages, located inside and outside the tumor. Immunohistological methods using monoclonal or polyclonal antibodies and enzyme histology were performed to identify different populations of infiltrative cells. In both variants of tumors an accumulation of these cells were seen at the periphery of the tumor, surrounding the nodules. In contrast, very few inflammatory cells, macrophages or T lymphocytes were seen inside the clumps of tumor cells where cytolytic cells could have a contact-dependent tumoricidal effect. Only small differences were found between progressive and regressive tumors in the density of the various populations of T helper, T cytotoxic/suppressor, B lymphocytes or macrophages inside or around the tumor nodules. On the other hand, progressive and regressive tumors clearly differ in the relationship between tumor cells and the fibroblastic reaction they induce. Regressive tumors were rapidly encircled by a fibroblastic reaction isolating them from the peripheral tissues. The fibroblastic reaction was less dense around the progressive tumor cells which were able to migrate and invade the periphery. This suggests that immunological factors leading to tumor progression or regression could act indirectly through a control of the fibroblastic reaction, rather than through a direct cytotoxic effect on the tumor cells.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3298078     DOI: 10.1002/ijc.2910400116

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  6 in total

1.  Factors influencing antibody-mediated cytotoxicity during the immunotherapy of Rauscher-virus-induced myeloid leukemic cells.

Authors:  D Berends; T H van der Kwast; N J de Both; P G Mulder
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

2.  Redistribution of fibroblasts and macrophages as micrometastases develop into established liver metastases.

Authors:  Nobuaki Higashi; Hideki Ishii; Takeshi Fujiwara; Megumi Morimoto-Tomita; Tatsuro Irimura
Journal:  Clin Exp Metastasis       Date:  2002       Impact factor: 5.150

3.  Association between invasiveness, inflammatory reaction, desmoplasia and survival in colorectal cancer.

Authors:  T B Halvorsen; E Seim
Journal:  J Clin Pathol       Date:  1989-02       Impact factor: 3.411

4.  Patho- and immunobiology of malignant mesothelioma: characterisation of tumour infiltrating leucocytes and cytokine production in a murine model.

Authors:  H Bielefeldt-Ohmann; D R Fitzpatrick; A L Marzo; A G Jarnicki; R P Himbeck; M R Davis; L S Manning; B W Robinson
Journal:  Cancer Immunol Immunother       Date:  1994-12       Impact factor: 6.968

5.  Early detection of tumour immune-rejection using magnetic resonance imaging.

Authors:  D-E Hu; D A Beauregard; M C Bearchell; L L Thomsen; K M Brindle
Journal:  Br J Cancer       Date:  2003-04-07       Impact factor: 7.640

6.  Podoplanin, α-smooth muscle actin or S100A4 expressing cancer-associated fibroblasts are associated with different prognosis in colorectal cancers.

Authors:  Song-Yi Choi; Rohyun Sung; Sang-Jeon Lee; Taek-Gu Lee; Nayoung Kim; Soon Man Yoon; Eun Jeoung Lee; Hee Bok Chae; Sei Jin Youn; Seon Mee Park
Journal:  J Korean Med Sci       Date:  2013-08-28       Impact factor: 2.153

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.